Certificate under Regulation 74(5) of SEBI (DP) Regulations 2018
Price
▲ positive · ▼ negative · ● neutral filings · teal = economic event · numbered = multiple that day (click to pick). Times IST.
Awaiting price reaction for this filing.
Kabra Drugs Ltd has submitted a routine compliance certificate to BSE for the quarter ended March 31, 2025. The certificate was issued by Skyline Financial Services Pvt Ltd, the company's Registrar and Share Transfer Agent. It confirms that physical share certificates received for dematerialization were properly verified, listed on the stock exchange, and the certificates were mutilated and cancelled, with the depository recorded as the new registered owner within the required 15-day timeline. This is a standard quarterly regulatory filing required under SEBI's depository regulations.
No material impact on shareholders or stock price. This is a routine procedural compliance filing confirming proper handling of share dematerialization requests, with no change to business operations or financial position.